Related Experiment Video
Updated: Oct 8, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Successful pregnancy with left ventricular assist device failure in the setting of peripartum cardiomyopathy
Aurelio Vargas1, Sabiha Armin1, Edward Yeomans2
1School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas.
Abstract:
Pregnancy is contraindicated for women with left ventricular dysfunction due to high maternal and fetal mortality. We present a case of a pregnant 31-year-old woman with a history of heart failure due to peripartum cardiomyopathy from a previous pregnancy. She had a left ventricular assist device (LVAD) and was on warfarin due to recurrent thrombosis of her device. During her course, she had multiple cardiac complications, including thrombosis of the LVAD, which required deactivation. At 32 weeks, a cesarean section was performed due to acute decompensation, and a transthoracic echocardiogram revealed a left ventricular ejection fraction of 30% to 34%, a dilated left ventricle, and moderate global hypokinesis. This case highlights the need for coordinated care from cardiologists and maternal-fetal medicine specialists to minimize symptoms to obtain ideal outcomes for mother and infant despite LVAD deactivation.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Valve Prolapse III: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy

